twit 25   linkedin 25

17 / Nov 02

Financial communication : FDA approval of Vyzulta

Valeant Pharmaceuticals International, Inc.’s wholly owned subsidiary, Bausch + Lomb, a leading global eye health company, and Nicox S.A., an french ophthalmic company, announced that the U.S. Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for VYZULTA™ (latanoprostene bunod ophthalmic solution, 0.024%)

About NewCap

As a specialist in investor relations and strategic communication advice, NewCap advises and supports its clients regarding their sectoral, scientific, institutional and financial communication strategies.

CONTACT

contact 01Address :
21, place de la Madeleine - 75008 Paris

contact 02Phone :
+33 (0)1 44 71 94 94

contact 03Email :
infos(at)newcap.fr